Position in VTRS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$3,620
+$1,216 QoQ
Shares Held
228
+28.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#847
of 1,016 holders
Holding Since
Dec 2020
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bay Harbor Wealth Management, LLC holds $63,968 across 13 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,000 | $33,880 | |
| 2 | HLN |
Haleon plc
|
1,000 | $9,330 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
11 | $5,960 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
31 | $5,224 | |
| 5 | VTRS |
Viatris Inc
This page
|
228 | $3,620 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
91 | $2,239 | |
| 7 | ALKS |
Alkermes plc.
|
23 | $1,205 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
9 | $998 |
All Filings in VTRS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,620 | 228 | Shares | Other | 2026-07-28 | |
| 2026-03-31 | $2,404 | 178 | Shares | Other | 2026-04-14 | |
| 2025-12-31 | $1,257 | 101 | Shares | Other | 2026-02-02 | |
| 2025-09-30 | $712 | 72 | Shares | Other | 2025-10-09 | |
| 2025-06-30 | $339 | 38 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $156 | 18 | Shares | Sole | 2025-05-12 | |
| 2020-12-31 | $393 | 21 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||